Global LEADERS Trial: head-to-head comparison of a biodegradeable polymer Biolimus A9 eluting stent (BioMatrix Flex) and a durable polymer drug-eluting stent.

Trial Profile

Global LEADERS Trial: head-to-head comparison of a biodegradeable polymer Biolimus A9 eluting stent (BioMatrix Flex) and a durable polymer drug-eluting stent.

Planning
Phase of Trial: Phase III

Latest Information Update: 20 May 2011

At a glance

  • Drugs Antiplatelets; Aspirin; Ticagrelor; Umirolimus
  • Indications Cardiovascular disorders; Coronary artery disease; Coronary artery restenosis; Embolism and thrombosis; Myocardial ischaemia
  • Focus Therapeutic Use
  • Acronyms Global LEADERS; LEADERS-II
  • Most Recent Events

    • 20 May 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top